NewsRoom Articles - Page 88 of 174

ThursdayDec 30, 2021 9:00 am

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Inches Closer to iSTRYM’s Commercial Deployment; Announces Dr. Doron Sagman’s Appointment as CMO; and Avails Recent Life Sciences Virtual Conference Presentation for On-Demand Viewing

MINDCURE just announced receiving its HIPAA certification for iSTRYM, its AI-powered, SaaS platform for psychedelic therapy This marks a key milestone for the company, having already exceeded its target of 10 partner clinics by the end of 2021 It also inches the company closer to the platform’s commercial deployment, set for the second quarter of 2022 This comes just in time, following the appointment of Dr. Doron Sagman as the company’s new CMO MINDCURE’s Life Sciences Virtual Conference Presentation will also be available for on-demand viewing 24/7 for the next 90 days Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) has…

WednesdayDec 29, 2021 9:30 am

Study Finds Factors That May Accurately Forecast Onset of Psychiatric Disorders

New research has found evidence that an extensive range of early onset psychiatric issues like ADHD, bulimia, dyslexia, anxiety and depression are primarily caused by psychological, social and biological factors. The objective of the study, which was conducted by scientists at McGill University, was to better understand the cause of psychiatric disorders. With regard to the factors that may cause these disorders to develop, the psychological factor is associated with temperament, in particular, difficulty controlling emotions and the tendency toward impulsivity. The social factor suggests the crucial role of early childhood abuse or neglect while the biological factor is in…

TuesdayDec 28, 2021 9:30 am

New Research Finds Higher Rates of Multiple Myeloma Precursor Condition in High-Risk Groups

A new study has found higher rates of a precursor condition for myeloma in older individuals who have a close family member with a past or current blood cancer as well as those who are Black. The study, which started in 2019, is the largest screening study to be carried out in the United States. It is being conducted by researchers from the Dana-Farber Cancer Institute, led by Irene Ghobrial. For their study, the researchers recruited more than 7,500 participants — 2,439 of the participates were Black. The objective of the study was to determine the rate of monoclonal gammopathy of…

MondayDec 27, 2021 11:14 am

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Recognized as One of the Best Women-Led Workplaces, Participates in the December 16 Life Sciences Virtual Investor Conference

The Great Place to Work organization included MINDCURE in its 2021 list of the Best Workplaces Managed by Women The company was recognized for its employee-oriented perks and programs, which include flexible working hours, monthly team-building events, and a remote work office stipend MINDCURE also participated in the Life Sciences Virtual Investor Conference held on December 16, where executives shared the company’s corporate vision and fielded questions from investors and other attendees Multiple studies have evidenced that women-led companies tend to perform better and are more likely to have more engaged, inspired, and satisfied employees than male-led firms. A Forbes…

MondayDec 27, 2021 9:30 am

Smart Patch Market Expected to Grow to $15 Billion by 2030

A smart patch is a wearable sensor used in the healthcare sector. The patch is usually applied to the skin of a patient using an adhesive and is used to monitor their condition, collecting data on parameters such as blood pressure and heart rate. After collecting the data, the patches share that information to connected electronic devices, including mobiles. Currently, the global market for these sensor-enabled patches is valued at about $8.5 billion. Forecasts show that the market will grow at a compound annual growth rate of 6% between 2022 and 2030 and will be valued at roughly $15.2 billion…

ThursdayDec 23, 2021 9:30 am

FDA Releases Clinical Trial Guidelines Taking into Account CNS Metastases

The Food and Drug Administration recently released new guidance informing sponsors of clinical trials on recommendations to trial designs for systemic oncologic treatments in individuals with central nervous system metastases. According to the new guidelines, researchers must consider leptomeningeal disease, end points, central nervous system assessment, prior therapies and patient population when designing clinical trials. The assessment of tumors is best done through magnetic resonance imaging (“MRI”) with gadolinium contrast. The agency recommends that the involvement of the central nervous system (“CNS”) not be assessed separately from other metastatic illnesses present in other parts of a patient’s body. It adds…

WednesdayDec 22, 2021 12:38 pm

Nemaura Medical Inc. (NASDAQ: NMRD) Complete Initial Shipment of sugarBEAT(R) Devices to UK Licensee

Nemaura Medical announced the successful completion of its initial shipment of sugarBEAT(R) continuous glucose monitor devices to its UK licensee The initial shipment, which comprised 5,000 CGM devices and 200,000 sensors, is expected to result in follow-on monthly orders of up to 2 million sensors and 15,000 CGM devices over the next two years Following the launch of the sugarBeat(R), Nemaura Medical have released the MiBoKo application, designed to help individuals track their metabolic health scores Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, revealed…

WednesdayDec 22, 2021 9:30 am

Study Finds That Mental Health Services Shortage is Frustrating Parents

A recently conducted survey has found that only 50% of parents who tried acquiring mental health services for their children during the coronavirus pandemic were successful in their attempts. The survey was carried out in September 2021 by DotCom Therapy, a pediatric teletherapy provider. The objective of the survey was to measure the effect of the pandemic on mental health in children, as well as how children were impacted by going back to physical classes after a year of online learning and the coronavirus lockdown. The survey collected responses from more than 1,000 guardians and parents in the United States…

TuesdayDec 21, 2021 2:00 pm

Addiction Psychiatrist Offers Coping Tips Against Drinking During Holidays

The holidays, family gatherings and holiday celebrations are often filled with fun, good food and alcohol on occasion. Individuals with alcohol addiction may be vulnerable during this time, especially if they’re being invited to places with booze. Ideally, not having alcohol around would be best, but that isn’t always possible. Addiction psychiatrist Dr. Lauren Grawert gives a few tips on how to handle situations like this. Grawert states that it’s good to have a preplanned response ready when you, as a recovering alcohol addict, are offered an alcoholic drink. She highlights that it should be something you’re comfortable saying. Here…

MondayDec 20, 2021 12:13 pm

RYAH Group Inc. (CSE: RYAH) Releases Medical Cannabis Report on Cancer and Adverse Cancer Treatment Effects

RYAH recently released report highlighting medical cannabis treatment for cancer and adverse effects of cancer treatment Data from 80,000 sessions logged between January 1, 2018 and November 15, 2021 tracked conditions including anxiety, cachexia, fatigue, pain, nausea, and stress 62% of patients reported a moderate experience using cannabis to treat cancer-related conditions RYAH supports cancer research and treatment with IoT product ecosystem comprised of volume-control devices, medicine-carrying components, mobile applications RYAH Group (CSE: RYAH), the leader in volume-control technology for plant-based medicine, recently released a medical cannabis report on cancer and the adverse effects of cancer treatment (https://ibn.fm/Es52b). Data from…